Aspergillus Conidia Activate the Complement by the Mannan-Binding Lectin C2 Bypass Mechanism

被引:38
作者
Dumestre-Perard, Chantal [1 ,2 ,3 ]
Lamy, Bertrand [3 ]
Aldebert, Delphine [2 ]
Lemaire-Vieille, Catherine [2 ]
Grillot, Renee [4 ]
Brion, Jean-Paul [5 ]
Gagnon, Jean [2 ]
Cesbron, Jean-Yves [2 ,3 ]
机构
[1] Univ Grenoble 1, CNRS, Lab Adaptat & Pathogenie Microorganismes, UMR5163,Inst Jean Roget, F-38042 Grenoble, France
[2] CHU Grenoble, CNRS, UMR 5163, F-38043 Grenoble, France
[3] CHU Grenoble, Immunol Lab, F-38043 Grenoble, France
[4] CHU Grenoble, Lab Parasitol Mycol, F-38043 Grenoble, France
[5] CHU Grenoble, Serv Malad Infect, Dept Med Aigue & Specialisee, F-38043 Grenoble, France
关键词
D O I
10.4049/jimmunol.181.10.7100
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Innate immunity is the major host defense against invasive aspergillosis. To determine whether the collectin mannan-binding lectin (MBL) is involved in the initial protective immunity through complement activation against opportunistic fungal infections caused by Aspergillus, we performed in vitro studies on 29 different strains of Aspergillus conidia from five different species. Incubation of Aspergillus conidia in human normal serum leads to activation of the alternative pathway, whereas neither the classical nor the lectin pathways through C4 and C2 cleavage are activated. Complement response to conidia was investigated using a MBL-deficient serum and reconstitution experiments were conducted with MBL/MASPs complexes. We found that MBL can directly support C3 activation by a C2 bypass mechanism. Finally, a stronger activation of the alternative pathway was observed for the clinical strains isolated from patients with invasive aspergillosis, compared with the environmental strains. The Journal of Immunology, 2008, 181: 7100-7105.
引用
收藏
页码:7100 / 7105
页数:6
相关论文
共 39 条
[1]   COMPUTER-ASSISTED KINETIC ASSAY FOR QUANTIFICATION OF TOTAL COMPLEMENT ACTIVITY [J].
ABBAL, M ;
TKACZUK, J ;
PRAUD, C ;
MSAYEH, F ;
OHAYON, E .
COMPLEMENT AND INFLAMMATION, 1991, 8 (02) :92-103
[2]   DIFFERENTIAL ELUTION OF CLQ, CLR AND CLS FROM HUMAN CL BOUND TO IMMUNE AGGREGATES - USE IN THE RAPID PURIFICATION OF CL SUB-COMPONENTS [J].
ARLAUD, GJ ;
SIM, RB ;
DUPLAA, AM ;
COLOMB, MG .
MOLECULAR IMMUNOLOGY, 1979, 16 (07) :445-450
[3]   Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus [J].
Ascioglu, S ;
Rex, JH ;
de Pauw, B ;
Bennett, JE ;
Bille, J ;
Crokaert, F ;
Denning, DW ;
Donnelly, JP ;
Edwards, JE ;
Erjavec, Z ;
Fiere, D ;
Lortholary, O ;
Maertens, J ;
Meis, JF ;
Patterson, TF ;
Ritter, J ;
Selleslag, D ;
Shah, PM ;
Stevens, DA ;
Walsh, TJ .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (01) :7-14
[4]   Complement proteins C1q and MBL are pattern recognition molecules that signal immediate and long-term protective immune functions [J].
Bohlson, Suzanne S. ;
Fraser, Deborah A. ;
Tenner, Andrea J. .
MOLECULAR IMMUNOLOGY, 2007, 44 (1-3) :33-43
[5]   Mannose-binding lectin: Clinical implications for infection, transplantation, and autoimmunity [J].
Bouwman, Lee H. ;
Roep, Bart O. ;
Roos, Anja .
HUMAN IMMUNOLOGY, 2006, 67 (4-5) :247-256
[6]   Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients:: A 6-year survey [J].
Cornillet, A. ;
Camus, C. ;
Nimubona, S. ;
Gandemer, V. ;
Tattevin, P. ;
Belleguic, C. ;
Chevrier, S. ;
Meunier, C. ;
Lebert, C. ;
Aupee, M. ;
Caulet-Maugendre, S. ;
Faucheux, M. ;
Lelong, B. ;
Leray, E. ;
Guiguen, C. ;
Gangneux, J. -P. .
CLINICAL INFECTIOUS DISEASES, 2006, 43 (05) :577-584
[7]   Glycosylphosphatidylinositol-anchored fungal polysaccharide in Aspergillus fumigatus [J].
Costachel, C ;
Coddeville, B ;
Latgé, JP ;
Fontaine, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (48) :39835-39842
[8]   Compliments from complement: a fourth pathway of complement activation? [J].
Daha, Mohamed R. ;
van Kooten, Cees ;
Roos, Anja .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (12) :3374-3376
[9]   MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway [J].
Dahl, MR ;
Thiel, S ;
Matsushita, M ;
Fujita, T ;
Willis, AC ;
Christensen, T ;
Vorup-Jensen, T ;
Jensenius, JC .
IMMUNITY, 2001, 15 (01) :127-135
[10]   New perspectives on mannan-binding lectin-mediated complement activation [J].
Degn, Soren E. ;
Thiel, Steffen ;
Jensenius, Jens C. .
IMMUNOBIOLOGY, 2007, 212 (4-5) :301-311